Stocks and InvestingStocks and Investing
Wed, May 10, 2023
Tue, May 9, 2023

William Plovanic Maintained (YMAB) at Strong Buy with Increased Target to $21 on, May 9th, 2023


Published on 2024-10-28 03:33:46 - WOPRAI, William Plovanic
  Print publication without navigation


William Plovanic of Canaccord Genuity, Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Strong Buy with Increased Target from $18 to $21 on, May 9th, 2023.

William has made no other calls on YMAB in the last 4 months.



There are 5 other peers that have a rating on YMAB. Out of the 5 peers that are also analyzing YMAB, 2 agree with William's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Etzer Darout of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, April 3rd, 2023
  • Alec Stranahan of "B of A Securities" Maintained at Hold and Held Target at $6 on, Saturday, April 1st, 2023


These are the ratings of the 3 analyists that currently disagree with William


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $11 on, Tuesday, April 4th, 2023
  • William Maughan of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $18 on, Friday, March 31st, 2023
  • Michael Ulz of "Morgan Stanley" Downgraded from Hold to Sell on, Friday, January 27th, 2023